Breaking #Proptech #Stock News Metrospaces (OTC: $MSPC) Seeks Beta Testers for MetroHouse, MetroCrowd Platforms; @metrospaces @Shokworks

Breaking #Proptech #Stock News Metrospaces (OTC: $MSPC) Seeks Beta Testers for MetroHouse, MetroCrowd Platforms; @metrospaces @Shokworks  

 

NEW YORK, NY, October 28, 2021 - Proptech stock news from Investorideas.com Newswire: Metrospaces, Inc. (OTC: MSPC), a PropTech company powered by Shokworks, will launch a beta version of its MetroHouse platform in mid-November, and one of its MetroCrowd platform in mid-December, and is looking for interested shareholders and potential investors to serve as testers. MetroHouse is designed to completely reframe the co-living model and to create unique and luxury residential destinations for digital nomads or nomadic capitalists who have used this pandemic to support the concept of company building from anywhere on the planet. MetroCrowd is a real-estate tokenization platform that democratizes the real-estate investing process.

 

Read this news, featuring MSPC in full at https://www.investorideas.com/news/2021/technology/10281MSPC-MetroHouse-MetroCrowd.asp

 

“We’re excited for our shareholders and potential investors to begin testing out MetroHouse and MetroCrowd,” Metrospaces CEO Oscar Brito said. “The feedback these industry experts provide will help us further highlight the competitive advantages and key features MetroHouse brings to the co-living ecosystem and MetroCrowd brings to real-estate investing.”

 

 

MetroHouse includes everything one needs to make the most of city life in one bill – rent, furnishings, high-speed WiFI, utilities and room cleaning. MetroHouse users will be part of a community, sharing wonderfully designed spaces with the comfort of being able to retreat to a fully furnished room at the end of the day.

 

MetroCrowd upgrades the real estate market to the 21^st century, allowing for the partial or total tokenization of properties. This innovation allows for automation of middlemen processes, increased liquidity, lowered barriers to investment and improved transparency. Due to these qualities, tokenization has been hailed as the beacon of future real estate investment.

 

The beta testing for each platform will include 200-300 users with mocked data content to provide a feel of what the live app will be. Testers will have the opportunity to review and test the web app as well as how to apply to rent a co-living space. The test will last 15 calendar days, with the launch of the full app happening in the second quarter of 2022. Those interested in becoming beta testers for MetroHouse can apply via this Google Form https://bit.ly/3nxqXvT prospective MetroCrowd beta testers can apply at this Google https://bit.ly/2ZyhGLO Feedback will be collected through dedicated Telegram channels.

 

“We feel good about where we are with the MetroHouse and MetroCrowd apps,” said Alejandro Laplana, CTO of Metrospaces. “It’s an exciting time to be part of the prop-tech industry and we can’t wait to see how beta testers respond.”

 

Safe Harbor Statement: Statements in this news release may be "forward-looking statements". Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Metrospaces Inc. undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

Metrospaces Inc.

 

Contacts:

Sara Burgos, sburgos@sunwestpr.com, (469) 221-1820

 

Paid News -Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring MSPC is a paid for news release on Investorideas.com  More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

About Investorideas.com https://www.investorideas.com/About/

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

 

 

TechSectorStocks.com - investing ideas in tech stocks- mobile payments, social media, AI and Robotics, Drone Stocks, GPS, Internet of Things (IoT)

 

Like Tech Stocks? View our Tech Stocks Directory

 

 

#Wearable #MedicalDevices Snapshot - (OTC: $GTCHD) (NYSE: $SENS) (Nasdaq: $GRMN) (Nasdaq: $DXCM) (Nasdaq: $GOOG) @senseonics @Garmin @Google; #artificialintelligence

 

#Wearable #MedicalDevices Snapshot - (OTC: $GTCHD) (NYSE: $SENS) (Nasdaq: $GRMN) (Nasdaq: $DXCM) (Nasdaq: $GOOG) @senseonics @Garmin @Google; #artificialintelligence

 

Point Roberts WA, Vancouver BC–October 27,  2021  – Investorideas.com (https://www.investorideas.com/), a global investor news source covering Artificial Intelligence (AI) issues a sector snapshot looking at the wearable medical device market, featuring technology company GBT Technologies Inc. (OTCPINK:GTCHD).  

 

Read this article, featuring GTCHD in full at https://www.investorideas.com/news/2021/artificial-intelligence/10271GTCHD-SENS-GRMN-DXCM-GOOG.asp

 

With ongoing developments in areas such as Internet of things (IoT) and Artificial Intelligence (AI), and given the backdrop of the COVID-19 pandemic, the demand for mobile or wearable medical devices is, understandably, on the rise. In fact, research published by Coherent Market Insights finds that the global wearable medical devices market, which was valued at approximately $29.83 billion USD in 2020, is projected to reach $50.89 billion by the end of 2027. This category encompasses wearable therapeutic devices, wearable monitoring and diagnostic devices, and health and fitness devices. And it’s not only, or even mainly, COVID-19 driving demand. According to the report’s summary, demand for wearable medical devices is expected to be driven by a “high prevalence of chronic diseases,” and an “increasing geriatric population.”

 

One company that recently announced plans for this space is GBT Technologies Inc. (OTC PINK:GTCHD). GBT, an early stage technology developer in (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms is now roadmapping a wearable version of its qTerm human vitals device. The current finger-touch version of the qTerm measures a user’s body temperature, blood oxygen level and heart rate. Danny Rittman, the company’s CTO, explained:

 

"It is only natural to create a wearable version of qTerm technology. One of the major advantages of a wearable form of qTerm is its capabilities to take health related measurements; independently, and without the user's awareness, this feature can be enabled upon the user's permission. We see this feature as a great advantage; especially, when users may forget to take their scheduled vitals, not aware of a potential problem. The wearable version of qTerm will be equipped with the same AI system for on-going health monitoring, and it will learn about a user's health condition and perform scheduled checks to ensure good health. These checks will be executed throughout the day or night and in case of abnormalities the user will be alerted, and can be an efficient health monitoring system for the elderly; 24/7. In qTerm's finger-touch version the responsibility to perform a vitals check lies on the user remembering to take these on time. However, with the wearable device the checks will be automatically executed throughout the day in case the user forgets their daily health-related duties, this system will do it for them. qTerm wearable will include a website synchronized mobile application for results representation. This advanced mobile application will make the qTerm wearable device a personal health monitoring system constantly on the watch, checking, analyzing and advising/alerting about any health concerns.”

 

Chronic diseases were cited as key drivers of the wearable medical device market by the aforementioned Coherent Market Insights report, and one such chronic disease is diabetes. Medical technology company Senseonics Holdings, Inc. (NYSEAmerican:SENS), which focuses on the development and commercialization of the long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, and Ascensia Diabetes Care, the makers of the CONTOUR family of diabetes blood glucose monitoring devices and commercialization partner for Senseonics, recently announced that the University Hospitals Accountable Care Organization (UHACO) in Cleveland, Ohio has begun offering the Eversense CGM System to its Medicare enrollees effective early September, 2021. According to the press release, the Eversense CGM System “consists of a fluorescence-based sensor, a smart transmitter worn over the sensor to facilitate data communication, and a mobile app for displaying glucose values, trends and alerts.” Betul Hatipoglu, M.D., Head of Endocrinology and Diabetes at UHACO, commented:

 

"We are excited to offer Eversense to our ACO patients with diabetes. Supplying tools for effective glucose management allows us to meet the Standards of Care for patients using insulin as outlined by the American Diabetes Association. Eversense offers patients choice amongst continuous glucose monitoring devices. The Eversense CGM system delivers industry leading accuracy, an improved patient experience, and an array of unique features that afford people, especially those in the Medicare population, the opportunity to achieve improved health outcomes."

 

Similarly, Garmin International, Inc., a unit of multinational tech firm Garmin Ltd. (NasdaqGS:GRMN), recently introduced the Dexcom Connect IQ apps, “providing people with Type 1 and Type 2 diabetes who use the Dexcom^® G6 Continuous Glucose Monitor (CGM) System¹ with a way to quickly see their glucose levels and trends – even while working out – right on their compatible Garmin smartwatch or cycling computer.” Jake Leach, CTO at Dexcom (NasdaqGS:DXCM), said:

 

"The addition of Garmin wearables and cycling computers to the Dexcom CGM ecosystem is an exciting advancement for Dexcom users who are now able to easily view and monitor their glucose levels from their favorite Garmin device. Garmin is our first partner to connect to Dexcom G6 through our new real-time API – showcasing the value of integrated CGM and further solidifying Dexcom G6 as the most powerful and connected CGM in the world."

 

Recently Onduo, part of life sciences research organization Verily, an independent subsidiary of Alphabet Inc. (NasdaqGS:GOOG), recently announced that it “will offer Fitbit devices and Fitbit Premium as part of the company’s approach to whole person health.” Fitbit is a subsidiary of Alphabet Inc.’s Google. Dr. Vindell Washington, MD, CEO of Onduo, said:

 

“With a mission to help people get healthier, Fitbit helps users manage their holistic health and wellness, making them a perfect complement to our whole-person health promise. Together with Fitbit, we’ll be able to better support condition-specific management and our members' overall health and wellness by providing new tools and actionable guidance to support their health journeys. For example, in using Fitbit Onduo members will receive Fitbit insights like how increased activity can decrease resting heart rate — and they will be able to proactively engage in the management of their activity, sleep and nutrition.”

 

Earlier this year, Royal Philips (NYSE:PHG) advanced the case for wearable devices for cardiac conditions with its acquisition of remote cardiac diagnostics and monitoring firm BioTelemetry, Inc. A Philips spokesperson told Medical Device Network:

 

“The acquisition of BioTelemetry will add to [Philips’ portfolio of] leading cardiac diagnostics and monitoring solutions, comprised of wearable connected heart monitors, AI-based data analytics and services. These clinically validated solutions are focused on the diagnosis and monitoring of heart rhythm disorders.

 

BioTelemetry provides services for over one million patients per year and has built the world’s largest remote cardiac monitoring services network. Acquiring BioTelemetry will further broaden and scale our patient care management solutions for the hospital and the home to enhance patient outcomes, streamline clinical workflows and increase productivity.”

 

So while future research might indicate more clearly the impact of COVID-19 on the market, it is clear that demand for wearable medical devices is well established and growing regardless.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Disclosure: GTCHD is a monthly paid featured AI/tech stock on Investorideas.com Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

Get more Technology stock investor ideas - news, articles, podcasts and stock directories

Breaking #AI #Stock News: GBT (OTCPK: $GTCHD) Files Patent For its Long-Range Radio System; #ArtificialIntelligence

Breaking #AI #Stock News: GBT (OTCPK: $GTCHD) Files Patent For its Long-Range Radio System; #ArtificialIntelligence

 

The Patent; an #AI-Empowered #Technology Enables Intelligent, Long Range #Communication Solutions

 

SAN DIEGO, CA October 27, 2021 - (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCHD) ("GBT” or the “Company”), filed with the U.S. Patent and Trademark Office (“USPTO”) a provisional patent, USPTO application #63257199, for its long-range radio system; Infinia (Internal project’s code name), a data and voice communication system, that is operating via HF (High Frequency) radio waves.

 

Read this news, featuring GBT in full at https://www.investorideas.com/CO/GOPH/news/2021/10271Patent-Long-Range-Radio.asp

 

The system communicates through an ionospheric propagation environment, one reaching very long distances. The patent covers an AI system and method to overcome any major long-range radio challenges, which communicate through skip zones where there is no reception. The proposed dead-zone coverage solution is based on AI geo-referenced analytics and management to enable continuous, reliable communications regardless of terrain, time of day or year, and other weather-related conditions.

 

This system and method analyze the ionospheric conditions and will automatically adjust frequencies, antenna power/position, and other additional factors to ensure a reliable and clear radio signal. Infinia GEN I radio part; successfully, passed short- and long-range rigorous testing, and is targeted for AI implementation for its GEN II release. The company targets the system potentially for military and civil applications, among these are remote telemedicine, civilian/military communication, emergency response, and remote internet services.

 

"A long-range radio system that can sustain any weather or terrain can be a great asset for civilian and military organizations. For example, remote areas telemedicine and emergency services or all terrain military communications. Our Infinia project, GEN I, has achieved great results and we filed a provisional patent with USPTO to further protect the system and method. As the system’s radio part was tested for its performance and capabilities, we plan to further equip it with our AI technology (GEN II), to create an intelligent, long-range communication solutions that can be used in many domains. The system successfully passed rigorous short and long-distance testing phases, and we will be evaluating commercial applications for it in the near future. The Infinia patent covers data and voice communications along with AI based methods and algorithms to establish continuous, reliable, clear and secured HF radio communication at all times. We consider our Infinia project one of our major Ips, and will further file for a comprehensive, non-provisional application in the next few months,” said Danny Rittman, the Company’s CTO.

 

There is no guarantee that the Company will be successful in researching, developing or implementing this system.  In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product.  There is no guarantee that the Company will be successful in any or all of these critical steps. 

 

About Us

GBT Technologies, Inc. (OTC PINK: GTCHD) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

 

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements".  Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov).  In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products.  The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change.  However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCHD) is a featured tech stock on

Investorideas.com

 

More info on GTCHD at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCHD

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCHD is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

  Get more tech stocks investor ideas- news, articles, podcasts and stock directories

 

 

 

#AIEye #Podcast 618: #Stocks discussed: (NYSE: $TDC) (TSXV: $DM.V) #artificialintelligence

 

 

#AIEye #Podcast 618: #Stocks discussed: (NYSE: $TDC) (TSXV: $DM.V) #artificialintelligence

 

Teradata Corporation and H2O.ai Announce Platform Integration for Enterpise AI, and Datametrex AI is Selected for Final Round for $40M AI Contract

 

#AI in #Healthcare Market to Exceed $34.5B in 2027

 

Point Roberts WA, Vancouver BC – October 25, 2021  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/102521-AI-Eye.mp3

 

Read this in full at

https://www.investorideas.com/news/2021/artificial-intelligence/10251TDC-DM.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (NYSE:TDC) (TSXV:DM)

 

Teradata Corporation (NYSE:TDC) and AI cloud company H2O.ai have announced the integration of H2O AI Hybrid Cloud, the latter’s state-of-the-art AI platform, with Vantage, Teradata’s multi-cloud data platform. This, according to the press release, will allow the two firms’ customers to “quickly and easily make, deploy, and operate AI solutions that solve business problems and drive business value.” Sri Ambati, Founder and CEO at H2O.ai, said:

 

"Customers tell us that disconnected data, analytics and AI platforms slow down their AI initiatives. The integration of H2O AI Hybrid Cloud with Teradata Vantage provides seamless alignment between the platforms, unifying data stores of all kinds, analytics and AI, so our customers can rapidly access more data to inform new insights that result in more accurate and informed business decisions."

 

Datametrex AI Limited (TSXV:DM) has been selected into the final round in the bidding process under a Requests for Proposals (RFP) on an Artificial Intelligence contract in Canada. The fully realized contract is worth approximately $40 million. Marshall Gunter, CEO of Datametrex, said:

 

"We are proud to be selected for the final round for this AI business and are excited by the possibilities this creates for our employees, customers, partners and shareholders. We are cautiously optimistic. We believe the growing momentum with AI will remain through 2022 as the overall economy improves and more organizations return to investing in technology. The team at Datametrex believes that we are uniquely positioned to continue leading in the AI market.”

 

 

AI in Healthcare Market to Exceed $34.5B in 2027

 

A report published by Global Market Insights finds that the market for AI in Healthcare is projected to grow from $4.2 billion USD in 2020 to over $34.5 billion in 2027 with a compound annual growth rate (CAGR) of 33.7 percent in the forecast period 2021-2027. An excerpt from the report summary reads:

 

Growing application of artificial intelligence in the field of drug discovery, medical imaging, precision medicine and genomics coupled with increasing personalized treatments will drive the market growth.

 

Moreover, the use of artificial intelligence and its broadening horizons in research areas is observed to foster market expansion. For instance, artificial intelligence is used for advanced treatments in oncology. The technology aids in detection of abnormalities in X-rays and MRIs, which can often be overlooked by the human eye.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

 

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

 

The Investorideas.com podcasts are also available on Apple Podcasts ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts  and most audio platforms available.

 

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

Get more Technology stock investor ideas - news, articles, podcasts and stock directories